1Dellaporta A.Central serous retinopathy. Trans Am Ophthalmol Soc,1976,74:144.
2Roberlson Dm, Tlstrapo Pirect.Indirect and sham laser photocoagulation in the management of central serous chorioretinopathy .Am J Ophthalmol,1983,95:475.
3Fickerl,Vafidis G,whileA,et al. Long -term results of treatment of central serous retinopathy-a preliminary report. Trans Ophthalmol Socuk,1986,105:473.
4Sluer . Knypron red laser photocoagulation in selected caser of central serous chonoretinophathy.Retina,1986,6:81.
5Fickerl,vafidis G,whileA,et al.Long-term follow-up of a prospectrve trial of argon laser photocoagu-lation in the treament of central serous retinopathy.Br J Ophthalmol,1988,72:829.
7Friberg TR. Central serous choriore tinopathy. Seminar in Ophthalmology,1991,6:36.
8Lu JG,Friberg TR. Idiopathic central serous retinopathy in china: areport of 600 cases treatedby acupucture.Ophthalmic Surg,1987,18:608.
9Lachapellek,Ballantynem,Cruess A. Chronic benign retinal pigment epithelial detachment :a subtype of central serous choroidopathy Can J Ophthalmol,1994, 29:70.
10Weinberger,Kremer,I,Sira IB The treatment of foveal Ceutral serous choroidopathy by krypton red laser. Ann Ophthalmol,1990,22:35.
1Wang M, Munch IC, Hasler PW, Prtinte C, Larsen M. Central se- rous chorioretinopathy [ J ]. Acta Ophthalmol, 2008,86 ( 2 ) : 126- 145.
2Carvalho-Recchia CA, Yammzzi LA, Negrao S, Spaide RF,Fre- und KB, Rodriguez-Coleman H, et al. Corticosteroids and central serous chorioretinopathy [ J ]. Ophthalmology, 2002,109 ( 10 ) : 1834-1837.
3Bowie EM, Folk JC, Barnes CH. Corticosteroids, central serous chorioretinopathy, and neurocysticercosis [ J ]. Arch Ophthal- tool, 2004,122 ( 2 ): 281-283.
4Kunavisarut P, Pathanapitoon K, Van Schooneveld M, Rothova A. Chronic central serous chorioretinopathy associated with se- rous retinal detachment in a series of Asian patients [ J ]. Ocul Immunol Inflamm, 2009,17 ( 4 ) : 269 -277.
5Kang JE, Kim H J, Boo HD, Kim HK, Lee JH. Surgical manage- ment of bilateral exudative retinal detachment associated with central serous chorioretinopathy [ J ]. Korean J Ophthalmol, 2006.20(2) :131-138.
6Sakamoto A,Hangai M,Yoshimura N. Spectral-domain optical co- herence tomography with multiple B-scan averaging for en- hanced imaging of retinal diseases [J ]. Ophthalmology, 2008, 115(5) :1071-1078.
7Srinivasan V J, Wojtkowski M, Witkin A J, Duker JS, Ko TH, Car- valho M, et al. VAgh definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography [ J ]. Ophthalmology, 2006,113 ( 11 ) : 2054-2065.
8Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes- Garcia L, et al. Rex4sed diagnostic criteria for Vogt-Koyanagi- Harada disease: report of an international committee on nomen- clature[ J]. Am J Ophthalmol,2001,131 ( 5 ) :647-652.
9Kato Y ,Yamamoto Y ,Tabuchi H, Fukushima A. Retinal pigment epithelium folds as a diagnostic femding of Vogt-Koyanagi-Hara- da disease[ J]. Jpn J ophthalmol,2013,57 ( 1 ) :90-94.
10Ishihara K, Hangai M, Kita M, Yoshimura N. Acute Vogt-Koyana- gi-Harada diaease in enhanced spectral-domain optical coher- ence tomography[J]. Ophthalmology,2009,116(9) :1799-1807.
